nach oben

Acta Neurochirurgica

Erschienen in:

01.04.2016 | Review Article - Brain Tumors

Treatment of high numbers of brain metastases with Gamma Knife radiosurgery: a review

verfasst von: Mustafa Aziz Hatiboglu, Saffet Tuzgen, Kerime Akdur, Eric L. Chang

Erschienen in: Acta Neurochirurgica | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

Effectiveness of stereotactic radiosurgery (SRS) has been shown in patients with one to four brain metastases. Work has been done to evaluate the role of SRS alone treatment without whole-brain radiation therapy in patients with more than four metastases. A recent multiinstitutional JLGK 0901 prospective study revealed the class-2 evidence that SRS without whole-brain radiation therapy is an effective treatment for patients up to 10 metastatic lesions. Several retrospective studies exist to show the efficacy and safety of SRS for patients with even more than 10 lesions. However, patient selection is very critical for SRS alone treatment. The PubMed database was searched using combinations of search terms and synonyms for multiple brain metastases, Gamma Knife and SRS published between January 1, 2005 and January 1, 2015 in order to address the effectiveness of Gamma Knife for patients with multiple brain metastases. Good performance status, controlled primary disease, total treated tumor volume of 15 cm³ or less have been found to be significant predictors for survival among patients with two or more brain lesions. The data suggest that SRS can be used and whole brain radiation therapy can be withheld in selected patients with multiple lesions to avoid acute or chronic adverse effects, especially neurocognitive decline, without causing survival disadvantage. In this review, we assessed the evidence for SRS treatment of patients with multiple brain metastases.

Andrews DW, Scott CB, Sperduto PW, Flanders AE, Gaspar LE, Schell MC, Werner-Wasik M, Demas W, Ryu J, Bahary JP, Souhami L, Rotman M, Mehta MP, Curran WJ Jr (2004) Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 363:1665–1672CrossRefPubMed

Aoyama H, Shirato H, Tago M, Nakagawa K, Toyoda T, Hatano K, Kenjyo M, Oya N, Hirota S, Shioura H, Kunieda E, Inomata T, Hayakawa K, Katoh N, Kobashi G (2006) Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 295:2483–2491CrossRefPubMed

Bhatnagar AK, Flickinger JC, Kondziolka D, Lunsford LD (2006) Stereotactic radiosurgery for four or more intracranial metastases. Int J Radiat Oncol Biol Phys 64:898–903CrossRefPubMed

Brewster AE, Hopwood P, Stout R, Burt PA, Thatcher N (1995) Single fraction prophylactic cranial irradiation for small cell carcinoma of the lung. Radiother Oncol 34:132–136CrossRefPubMed

Chang EL, Wefel JS, Hess KR, Allen PK, Lang FF, Kornguth DG, Arbuckle RB, Swint JM, Shiu AS, Maor MH, Meyers CA (2009) Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 10:1037–1044CrossRefPubMed

Chang WS, Kim HY, Chang JW, Park YG, Chang JH (2010) Analysis of radiosurgical results in patients with brain metastases according to the number of brain lesions: is stereotactic radiosurgery effective for multiple brain metastases? J Neurosurg 113(Suppl):73–78PubMed

Chin LS, Ma L, DiBiase S (2001) Radiation necrosis following gamma knife surgery: a case-controlled comparison of treatment parameters and long-term clinical follow up. J Neurosurg 94:899–904CrossRefPubMed

Eaton BR, La Riviere MJ, Kim S, Prabhu RS, Patel K, Kandula S, Oyesiku N, Olson J, Curran W, Shu HK, Crocker I (2015) Hypofractionated radiosurgery has a better safety profile than single fraction radiosurgery for large resected brain metastases. J Neurooncol 123:103–111CrossRefPubMed

El Gantery MM, Abd El Baky HM, El Hossieny HA, Mahmoud M, Youssef O (2014) Management of brain metastases with stereotactic radiosurgery alone versus whole brain irradiation alone versus both. Radiat Oncol 9:116CrossRefPubMedPubMedCentral

10.

Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, McKenna WG, Byhardt R (1997) Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37:745–751CrossRefPubMed

11.

Gavrilovic IT, Posner JB (2005) Brain metastases: epidemiology and pathophysiology. J Neurooncol 75:5–14CrossRefPubMed

12.

Grandhi R, Kondziolka D, Panczykowski D, Monaco EA 3rd, Kano H, Niranjan A, Flickinger JC, Lunsford LD (2012) Stereotactic radiosurgery using the Leksell Gamma Knife Perfexion unit in the management of patients with 10 or more brain metastases. J Neurosurg 117:237–245CrossRefPubMed

13.

Higuchi Y, Serizawa T, Nagano O, Matsuda S, Ono J, Sato M, Iwadate Y, Saeki N (2009) Three-staged stereotactic radiotherapy without whole brain irradiation for large metastatic brain tumors. Int J Radiat Oncol Biol Phys 74:1543–1548CrossRefPubMed

14.

Hillard VH, Shih LL, Chin S, Moorthy CR, Benzil DL (2003) Safety of multiple stereotactic radiosurgery treatments for multiple brain lesions. J Neurooncol 63:271–278CrossRefPubMed

15.

Jairam V, Chiang VL, Yu JB, Knisely JP (2013) Role of stereotactic radiosurgery in patients with more than four brain metastases. CNS Oncol 2:181–193CrossRefPubMed

16.

Karlsson B, Hanssens P, Wolff R, Soderman M, Lindquist C, Beute G (2009) Thirty years’ experience with Gamma Knife surgery for metastases to the brain. J Neurosurg 111:449–457CrossRefPubMed

17.

Kim CH, Im YS, Nam DH, Park K, Kim JH, Lee JI (2008) Gamma knife radiosurgery for ten or more brain metastases. J Korean Neurosurg Soc 44:358–363CrossRefPubMedPubMedCentral

18.

Kocher M, Soffietti R, Abacioglu U, Villa S, Fauchon F, Baumert BG, Fariselli L, Tzuk-Shina T, Kortmann RD, Carrie C, Ben Hassel M, Kouri M, Valeinis E, van den Berge D, Collette S, Collette L, Mueller RP (2011) Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study. J Clin Oncol 29:134–141CrossRefPubMedPubMedCentral

19.

Kondziolka D, Lunsford LD, Flickinger JC (1999) The radiobiology of radiosurgery. Neurosurg Clin N Am 10:157–166PubMed

20.

Kondziolka D, Patel A, Lunsford LD, Kassam A, Flickinger JC (1999) Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys 45:427–434CrossRefPubMed

21.

Korytko T, Radivoyevitch T, Colussi V, Wessels BW, Pillai K, Maciunas RJ, Einstein DB (2006) 12 Gy gamma knife radiosurgical volume is a predictor for radiation necrosis in non-AVM intracranial tumors. Int J Radiat Oncol Biol Phys 64:419–424CrossRefPubMed

22.

Kumar T, Rakowski J, Zhao B, Alkhafaji M, Burmeister J, Austin T, Vlachaki M (2010) Helical TomoTherapy versus sterotactic Gamma Knife radiosurgery in the treatment of single and multiple brain tumors: a dosimetric comparison. J Appl Clin Med Phys 11:3245PubMed

23.

Kurtz JM, Gelber R, Brady LW, Carella RJ, Cooper JS (1981) The palliation of brain metastases in a favorable patient population: a randomized clinical trial by the radiation therapy oncology group. Int J Radiat Oncol Biol Phys 7:891–895CrossRefPubMed

24.

Larson DA, Flickinger JC, Loeffler JS (1993) The radiobiology of radiosurgery. Int J Radiat Oncol Biol Phys 25:557–561CrossRefPubMed

25.

Ma L, Nichol A, Hossain S, Wang B, Petti P, Vellani R, Higby C, Ahmad S, Barani I, Shrieve DC, Larson DA, Sahgal A (2014) Variable dose interplay effects across radiosurgical apparatus in treating multiple brain metastases. Int J Comput Assist Radiol Surg 1079-1086

26.

McDonald D, Schuler J, Takacs I, Peng J, Jenrette J, Vanek K (2014) Comparison of radiation dose spillage from the Gamma Knife Perfexion with that from volumetric modulated arc radiosurgery during treatment of multiple brain metastases in a single fraction. J Neurosurg 121(Suppl):51–59PubMed

27.

Mohammadi AM, Recinos PF, Barnett GH, Weil RJ, Vogelbaum MA, Chao ST, Suh JH, Marko NF, Elson P, Neyman G, Angelov L (2012) Role of Gamma Knife surgery in patients with 5 or more brain metastases. J Neurosurg 117(Suppl):5–12PubMed

28.

Park SH, Hwang SK, Kang DH, Lee SH, Park J, Hwang JH, Hamm IS, Park YM (2009) Gamma knife radiosurgery for multiple brain metastases from lung cancer. J Clin Neurosci 16:626–629CrossRefPubMed

29.

Posner JB (1992) Management of brain metastases. Rev Neurol (Paris) 148:477–487

30.

Raldow AC, Chiang VL, Knisely JP, Yu JB (2013) Survival and intracranial control of patients with 5 or more brain metastases treated with gamma knife stereotactic radiosurgery. Am J Clin Oncol 36:486–490CrossRefPubMed

31.

Rava P, Leonard K, Sioshansi S, Curran B, Wazer DE, Cosgrove GR, Noren G, Hepel JT (2013) Survival among patients with 10 or more brain metastases treated with stereotactic radiosurgery. J Neurosurg 119:457–462CrossRefPubMed

32.

Regis J, Tamura M, Guillot C, Yomo S, Muraciolle X, Nagaje M, Arka Y, Porcheron D (2009) Radiosurgery with the world's first fully robotized Leksell Gamma Knife PerfeXion in clinical use: a 200-patient prospective, randomized, controlled comparison with the Gamma Knife 4C. Neurosurgery 64:346–355, discussion 355-346 CrossRefPubMed

33.

Sahgal A, Barani IJ, Novotny J Jr, Zhang B, Petti P, Larson DA, Ma L (2010) Prescription dose guideline based on physical criterion for multiple metastatic brain tumors treated with stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 78:605–608CrossRefPubMed

34.

Serizawa T, Hirai T, Nagano O, Higuchi Y, Matsuda S, Ono J, Saeki N (2010) Gamma knife surgery for 1-10 brain metastases without prophylactic whole-brain radiation therapy: analysis of cases meeting the Japanese prospective multi-institute study (JLGK0901) inclusion criteria. J Neurooncol 98:163–167CrossRefPubMed

35.

Serizawa T, Iuchi T, Ono J, Saeki N, Osato K, Odaki M, Ushikubo O, Hirai S, Sato M, Matsuda S (2000) Gamma knife treatment for multiple metastatic brain tumors compared with whole-brain radiation therapy. J Neurosurg 93(Suppl 3):32–36PubMed

36.

Serizawa T, Yoshinori H, Osamu N, Yasunori S, Masaaki Y, Junichi O, Naokatsu S, Akifumi M, Tatsuo H (2012) Analysis of 2000 cases treated with gamma knife surgery: validating eligibility criteria for a prospective multi-institutional study of stereotactic radiosurgery alone for treatment of patients with 1-10 brain metastases (JLGK0901) in Japan. J Radiosurg SBRT 2:19–27

37.

Shaw E, Scott C, Souhami L, Dinapoli R, Kline R, Loeffler J, Farnan N (2000) Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys 47:291–298CrossRefPubMed

38.

Tallet AV, Azria D, Barlesi F, Spano JP, Carpentier AF, Goncalves A, Metellus P (2012) Neurocognitive function impairment after whole brain radiotherapy for brain metastases: actual assessment. Radiat Oncol 7:77CrossRefPubMedPubMedCentral

39.

Taylor BF, Yu JB, Kinsley J, Chiang VL (2013) Can the Karolinska adverse radiation effect (KARE) factor predict radiosurgical treatment-related imaging changes (tricks)? J Radiosurg SBRT 2:67

40.

Yamamoto M, Ide M, Nishio S, Urakawa Y (2002) Gamma Knife radiosurgery for numerous brain metastases: is this a safe treatment? Int J Radiat Oncol Biol Phys 53:1279–1283CrossRefPubMed

41.

Yamamoto M, Kawabe T, Sato Y, Higuchi Y, Nariai T, Barfod BE, Kasuya H, Urakawa Y (2013) A case-matched study of stereotactic radiosurgery for patients with multiple brain metastases: comparing treatment results for 1-4 vs ≥ 5 tumors: clinical article. J Neurosurg 118:1258–1268CrossRefPubMed

42.

Yamamoto M, Serizawa T, Shuto T, Akabane A, Higuchi Y, Kawagishi J, Yamanaka K, Sato Y, Jokura H, Yomo S, Nagano O, Kenai H, Moriki A, Suzuki S, Kida Y, Iwai Y, Hayashi M, Onishi H, Gondo M, Sato M, Akimitsu T, Kubo K, Kikuchi Y, Shibasaki T, Goto T, Takanashi M, Mori Y, Takakura K, Saeki N, Kunieda E, Aoyama H, Momoshima S, Tsuchiya K (2014) Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study. Lancet Oncol 15:387–395CrossRefPubMed

43.

Yang CC, Ting J, Wu X, Markoe A (1998) Dose volume histogram analysis of the gamma knife radiosurgery treating twenty-five metastatic intracranial tumors. Stereotact Funct Neurosurg 70(Suppl 1):41–49CrossRefPubMed

Titel: Treatment of high numbers of brain metastases with Gamma Knife radiosurgery: a review
verfasst von: Mustafa Aziz Hatiboglu
Saffet Tuzgen
Kerime Akdur
Eric L. Chang
Publikationsdatum: 01.04.2016
Verlag: Springer Vienna
Erschienen in: Acta Neurochirurgica / Ausgabe 4/2016
Print ISSN: 0001-6268
Elektronische ISSN: 0942-0940
DOI: https://doi.org/10.1007/s00701-016-2707-6

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2016

Hemodynamic alterations after stent implantation in 15 cases of intracranial aneurysm

How I do it: the combined petrosectomy

Isolated dystypia after subthalamic nucleus deep brain stimulation in a patient with Parkinson’s disease

The efficacy of gamma knife radiosurgery alone as a primary treatment for intracranial dural arteriovenous fistulas

Transaqueductal trans-Magendie fenestration of arachnoid cyst in the posterior fossa